Table 3.

Adjusted logistic regression model assessing the impact of Tele-Harm Reduction for buprenorphine treatment on three-month retention.

Characteristic	aOR	95% CI
Age	0.99	0.95, 1.05
Biological sex
Male	2.45	0.60, 9.99
Female	Ref	Ref
Race/ethnicity
Non-Hispanic Black	0.48	0.09, 2.47
Hispanic	0.84	0.23, 3.04
Non-Hispanic White	Ref	Ref
Insurance status at enrolment
Uninsured	0.39	0.07, 2.09
Underinsured	4.71	0.37, 59.69
Insured	Ref	Ref
Housing status at enrolment
Unstably Housed (in shelter)	2.43	0.60, 9.83
Rough sleeping (street)	1.33	0.28, 6.34
Stably Housed	Ref	Ref
Stimulant use at baseline
Yes	0.29	0.09, 0.93
No	Ref	Ref
Escalated buprenorphine dose post baseline
Yes	8.09	1.83, 35.87
No	Ref	Ref
Saw provider via Telehealth in first three months
Yes	7.53	2.36, 23.98
No	Ref	Ref

Note. Bolded represents a p value <.05.